Osaic Holdings
ATOS icon

Osaic Holdings’s Atossa Therapeutics ATOS Stock Holding History

Osaic Holdings’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13K Hold
587
– – ﹤0.01% 7446
2026
Q1 		$3.09K Sell
587
-3
-0.5% -$19 ﹤0.01% 6891
2025
Q4 		$5.22K Hold
590
– – ﹤0.01% 6683
2025
Q3 		$7.36K Hold
590
– – ﹤0.01% 6543
2025
Q2 		$7.34K Buy
590
+23
+4% +$275 ﹤0.01% 6335
2025
Q1 		$5.7K Sell
567
-3
-0.5% -$36 ﹤0.01% 6105
2024
Q4 		$8.04K Sell
570
-110
-16% -$2.15K ﹤0.01% 5920
2024
Q3 		$15.5K Sell
680
-50
-7% -$1.01K ﹤0.01% 5532
2024
Q2 		$13K Sell
730
-40
-5% -$885 ﹤0.01% 5617
2024
Q1 		$20.8K Hold
770
– – ﹤0.01% 5342
2023
Q4 		$10.2K Sell
770
-146
-16% -$1.57K ﹤0.01% 5823
2023
Q3 		$10.1K Sell
916
-100
-10% -$1.45K ﹤0.01% 5912
2023
Q2 		$19.2K Sell
1,016
-16
-2% -$194 ﹤0.01% 5589
2023
Q1 		$11.2K Sell
1,032
-84
-8% -$937 ﹤0.01% 5915
2022
Q4 		$9K Sell
1,116
-204
-15% -$2.34K ﹤0.01% 5980
2022
Q3 		$17K Hold
1,320
– – ﹤0.01% 5689
2022
Q2 		$22K Hold
1,320
– – ﹤0.01% 5536
2022
Q1 		$25K Sell
1,320
-56
-4% -$1.14K ﹤0.01% 5547
2021
Q4 		$33K Sell
1,376
-52
-4% -$1.9K ﹤0.01% 5440
2021
Q3 		$70K Buy
1,428
+99
+7% +$5.76K ﹤0.01% 4832
2021
Q2 		$127K Sell
1,329
-260
-16% -$13.8K ﹤0.01% 4273
2021
Q1 		$50K Buy
1,589
+1,522
+2,272% +$55.6K ﹤0.01% 4877
2020
Q4 		$1K Hold
67
– – ﹤0.01% 6170
2020
Q3 		$2K Buy
+67
New +$3.22K ﹤0.01% 5817

Other funds holding ATOS

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Osaic Holdings's ATOS Position: Q2 2026 in Review

Osaic Holdings held its Atossa Therapeutics (ATOS) position steady in Q2 2026 at 587 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #7446.

Osaic Holdings first reported a position in ATOS in Q3 2020 and has held it in 24 quarters since. The position peaked at $127K in Q2 2021. 31 funds tracked by Wall St. Rank hold ATOS as of Q2 2026.

  • Osaic Holdings held 587 shares of Atossa Therapeutics worth $1.13K as of Q2 2026.
  • Osaic Holdings left its Atossa Therapeutics share count unchanged in Q2 2026.
  • Atossa Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7446 holding.
  • Osaic Holdings first reported a position in Atossa Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • Osaic Holdings's Atossa Therapeutics position peaked at $127K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.